D.E. Shaw & Co’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.5K | Sell |
26,752
-192
| -0.7% | -$413 | ﹤0.01% | 2927 |
|
|
2025
Q1 | $118K | Sell |
26,944
-20,670
| -43% | -$90.3K | ﹤0.01% | 2828 |
|
|
2024
Q4 | $222K | Buy |
+47,614
| New | +$222K | ﹤0.01% | 2702 |
|
|
2020
Q4 | – | Sell |
-24,236
| Closed | -$250K | – | 2697 |
|
|
2020
Q3 | $250K | Buy |
+24,236
| New | +$250K | ﹤0.01% | 2342 |
|
|
2020
Q2 | – | Sell |
-60,516
| Closed | -$592K | – | 2601 |
|
|
2020
Q1 | $592K | Sell |
60,516
-130,648
| -68% | -$1.28M | ﹤0.01% | 2081 |
|
|
2019
Q4 | $2.2M | Sell |
191,164
-38,262
| -17% | -$441K | ﹤0.01% | 1556 |
|
|
2019
Q3 | $1.25M | Buy |
229,426
+96,316
| +72% | +$525K | ﹤0.01% | 1775 |
|
|
2019
Q2 | $1.58M | Buy |
133,110
+107,210
| +414% | +$1.27M | ﹤0.01% | 1708 |
|
|
2019
Q1 | $136K | Sell |
25,900
-700
| -3% | -$3.68K | ﹤0.01% | 2420 |
|
|
2018
Q4 | $84K | Sell |
26,600
-39,251
| -60% | -$124K | ﹤0.01% | 2472 |
|
|
2018
Q3 | $398K | Sell |
65,851
-21,598
| -25% | -$131K | ﹤0.01% | 2165 |
|
|
2018
Q2 | $463K | Buy |
87,449
+54,727
| +167% | +$290K | ﹤0.01% | 2178 |
|
|
2018
Q1 | $190K | Buy |
+32,722
| New | +$190K | ﹤0.01% | 2380 |
|
|
2017
Q2 | – | Sell |
-18,315
| Closed | -$49K | – | 2388 |
|
|
2017
Q1 | $49K | Buy |
+18,315
| New | +$49K | ﹤0.01% | 2376 |
|
|
2016
Q4 | – | Sell |
-14,149
| Closed | -$58K | – | 2464 |
|
|
2016
Q3 | $58K | Sell |
14,149
-77,056
| -84% | -$316K | ﹤0.01% | 2441 |
|
|
2016
Q2 | $288K | Buy |
+91,205
| New | +$288K | ﹤0.01% | 2255 |
|
|
2015
Q3 | – | Sell |
-10,042
| Closed | -$163K | – | 2528 |
|
|
2015
Q2 | $163K | Buy |
+10,042
| New | +$163K | ﹤0.01% | 2500 |
|
|
2014
Q4 | – | Sell |
-5,945
| Closed | -$203K | – | 2462 |
|
|
2014
Q3 | $203K | Buy |
+5,945
| New | +$203K | ﹤0.01% | 2191 |
|